← Open Payments lookup

EJINE OKOROAFOR: Open Payments

NPI 1003164377 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,953 in 132 payments from 15 companies in 2025. Trend: 2023 $1,758 · 2024 $2,479 · 2025 $2,953

Food & beverage: $2,953
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$478
Alkermes, Inc.18$432
Otsuka America Pharmaceutical, Inc.18$353
ABBVIE INC.14$302
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$241
E.R. Squibb & Sons, L.L.C.13$235
Vanda Pharmaceuticals Inc.8$212
Lundbeck LLC10$202
Axsome Therapeutics, Inc.8$143
Almatica Pharma LLC6$141

Products named: INGREZZA, REXULTI, ARISTADA, VRAYLAR, CAPLYTA, COBENFY, FANAPT, Auvelity.

Industry payments across NV — which companies pay providers there.